CHI Advisors LLC
NEW YORK, NY · CIK 1791468 · 13F filing filed 2023-11-13
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityCHI ADVISORS LLC (US)
- Others nearbyNew York, NY
$252.1m
reported value
-23.5% vs Q2 2023
26positions
81.4%in top 10
4 new
8 added
8 reduced
3 sold out
vs Q2 2023
Options: 2 call positions ($212.5k notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q3 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PLIANT THERAPEUTICS INC PLRX | $52.3m20.73% | Reduced -102.8k |
| REPARE THERAPEUTICS INC RPTX | $35.8m14.22% | Reduced -32.1k |
| CULLINAN THERAPEUTICS INC CGEM | $30.9m12.26% | Unchanged |
| ACELYRIN INC COM | $23.0m9.13% | Reduced -400.8k |
| ORCHARD THERAPEUTICS PLC SPON ADS NEW | $14.0m5.57% | Added +11.6m |
| LARIMAR THERAPEUTICS INC LRMR | $13.5m5.35% | Unchanged |
| KEROS THERAPEUTICS INC KROS | $13.0m5.15% | Added +5.5k |
| IKENA ONCOLOGY INC COM | $9.4m3.75% | Added +58.9k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $7.7m3.04% | Added +130.0k |
| COMPASS THERAPEUTICS INC CMPX | $5.6m2.21% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $5.4m2.14% | New |
| INOZYME PHARMA INC COM | $5.3m2.12% | Added +75.0k |
| SYROS PHARMACEUTICALS INC SYRS | $5.1m2.03% | Added +531.9k |
| BLUEPRINT MEDICINES CORP BPMC | $4.7m1.85% | New |
| DIREXION SHS ETF TR LABD | $4.6m1.84% | Reduced -100.0k |
| 2SEVENTY BIO INC TSVT | $3.9m1.56% | Added +150.0k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $3.4m1.36% | New |
| OVID THERAPEUTICS INC OVID | $3.3m1.32% | Unchanged |
| SAGIMET BIOSCIENCES INC SGMT | $3.1m1.22% | New |
| OMEGA THERAPEUTICS INC COMMON STOCK | $2.3m0.90% | Unchanged |
| BLACK DIAMOND THERAPEUTICS I BDTX | $2.1m0.82% | Reduced -30.0k |
| RALLYBIO CORP COM | $1.3m0.52% | Reduced -152.0k |
| DISC MEDICINE INC IRON | $1.2m0.47% | Reduced -100.1k |
| GRAPHITE BIO INC GRPH | $572.7k0.23% | Unchanged |
| FREELINE THERAPEUTICS HLDGS SPONSORED ADS | $372.6k0.15% | Added +65.0k |
| PRECISION BIOSCIENCES INC COM | $207.0k0.08% | Reduced -996.9k |
Sold out since Q2 2023
| Security | Value then |
|---|---|
| VECTIVBIO HLDG AG | $46.9m2.8m shares |
| HOOKIPA PHARMA INC | $694.1k788.7k shares |
| CORVUS PHARMACEUTICALS INC CRVS | $458.0k200.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| REPARE THERAPEUTICS INC RPTX · Call | $157.5k50.0k shares | New |
| PLIANT THERAPEUTICS INC PLRX · Call | $55.0k137.5k shares | Added |